Allarity Therapeutics (NASDAQ:ALLR) Upgraded by Wall Street Zen to “Hold” Rating
Allarity Therapeutics (NASDAQ:ALLR – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday. Allarity Therapeutics Trading Down 3.3% Shares of NASDAQ:ALLR opened at $1.03 on Thursday. Allarity Therapeutics has a 52-week low of […]
